e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Biomarkers, diagnosis and outcome of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution
M. Ariza, L. Molinos, J. Cason, A. Enriquez, A. Pando, D. Fole, H. Buchelli, P. Casan (Oviedo, Spain)
Source:
Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Session:
Biomarkers, diagnosis and outcome of respiratory infections
Session type:
Thematic Poster Session
Number:
2701
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ariza, L. Molinos, J. Cason, A. Enriquez, A. Pando, D. Fole, H. Buchelli, P. Casan (Oviedo, Spain). Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution. Eur Respir J 2013; 42: Suppl. 57, 2701
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Community acquired lung respiratory infections in HIV-infected patients: Microbial etiology and outcome
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Risk factors for pleural complications in children with community acquired pneumonia
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Severity scores and management of community acquired pneumonia
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Community acquired pneumonia in asthma patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Patterns of antibiotic prescribing for pneumonia at the outpatient to inpatient transition
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
The results of immunotherapy of community acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Clinical features of nursing and healthcare-associated pneumonia in patients who underwent tube feeding
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Evaluation of adherence to tuberculosis screening in children
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Etiological features of nosocomial pneumonia in neurosurgical intensive care unit. Update 2013
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Comparison of health care associated pneumonia and community acquired pneumonia in Turkish Thoracic Society pneumonia database
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept